Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Long-Term Debt : ¥241 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Long-Term Debt?

Tianjin Pharmaceutical Da Ren Tang Group's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥241 Mil.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly Long-Term Debt declined from Sep. 2023 (¥241 Mil) to Dec. 2023 (¥241 Mil) but then stayed the same from Dec. 2023 (¥241 Mil) to Mar. 2024 (¥241 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual Long-Term Debt increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥151 Mil) and increased from Dec. 2022 (¥151 Mil) to Dec. 2023 (¥241 Mil).

Tianjin Pharmaceutical Da Ren Tang Group Long-Term Debt Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Long-Term Debt Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

30.00

151.30

241.04

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															253.54	241.44	241.44	241.04	241.04

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Tianjin Pharmaceutical Da Ren Tang Group Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Long-Term Debt

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines